These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 30472944)

  • 1. Anti-amyloid Therapy of Alzheimer's Disease: Current State and Prospects.
    Kozin SA; Barykin EP; Mitkevich VA; Makarov AA
    Biochemistry (Mosc); 2018 Sep; 83(9):1057-1067. PubMed ID: 30472944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New biomarkers and drug targets for diagnosis and therapy of Alzheimer's disease (molecular determinants of zinc-dependent oligomerization of Β-amyloid)].
    Kozin SA; Makarov AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(1):5-9. PubMed ID: 25909782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural aspects of Alzheimer's disease immunotherapy targeted against amyloid-beta peptide.
    Cehlar O; Skrabana R; Revajova V; Novak M
    Bratisl Lek Listy; 2018; 119(4):201-204. PubMed ID: 29663816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The murine version of BAN2401 (mAb158) selectively reduces amyloid-β protofibrils in brain and cerebrospinal fluid of tg-ArcSwe mice.
    Tucker S; Möller C; Tegerstedt K; Lord A; Laudon H; Sjödahl J; Söderberg L; Spens E; Sahlin C; Waara ER; Satlin A; Gellerfors P; Osswald G; Lannfelt L
    J Alzheimers Dis; 2015; 43(2):575-88. PubMed ID: 25096615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aβ-Immunotherapeutic strategies: a wide range of approaches for Alzheimer's disease treatment.
    Montoliu-Gaya L; Villegas S
    Expert Rev Mol Med; 2016 Jun; 18():e13. PubMed ID: 27357999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid β-targeted metal complexes for potential applications in Alzheimer's disease.
    Liu H; Qu Y; Wang X
    Future Med Chem; 2018 Mar; 10(6):679-701. PubMed ID: 29400551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-Based Drugs and Approaches Against Amyloid-β Species for Alzheimer's Disease Immunotherapy.
    Liu J; Yang B; Ke J; Li W; Suen WC
    Drugs Aging; 2016 Oct; 33(10):685-697. PubMed ID: 27699633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationally Designed Peptides and Peptidomimetics as Inhibitors of Amyloid-β (Aβ) Aggregation: Potential Therapeutics of Alzheimer's Disease.
    Goyal D; Shuaib S; Mann S; Goyal B
    ACS Comb Sci; 2017 Feb; 19(2):55-80. PubMed ID: 28045249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Passive Aβ Immunotherapy: Current Achievements and Future Perspectives.
    Schilling S; Rahfeld JU; Lues I; Lemere CA
    Molecules; 2018 May; 23(5):. PubMed ID: 29751505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do We Need Anti-Prion Compounds to Treat Alzheimer's Disease?
    Willbold D; Kutzsche J
    Molecules; 2019 Jun; 24(12):. PubMed ID: 31208037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel strategies for Alzheimer's disease treatment: An overview of anti-amyloid beta monoclonal antibodies.
    Rygiel K
    Indian J Pharmacol; 2016; 48(6):629-636. PubMed ID: 28066098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of huprine X on β-amyloid, synaptophysin and α7 neuronal nicotinic acetylcholine receptors in the brain of 3xTg-AD and APPswe transgenic mice.
    Hedberg MM; Clos MV; Ratia M; Gonzalez D; Lithner CU; Camps P; Muñoz-Torrero D; Badia A; Giménez-Llort L; Nordberg A
    Neurodegener Dis; 2010; 7(6):379-88. PubMed ID: 20689242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective neutralization of APP-C99 with monoclonal antibodies reduces the production of Alzheimer's Aβ peptides.
    Houacine J; Bolmont T; Aeschbach L; Oulad-Abdelghani M; Fraering PC
    Neurobiol Aging; 2012 Nov; 33(11):2704-14. PubMed ID: 22317957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of retro-inverso peptides as anti-aggregation drugs for β-amyloid in Alzheimer's disease.
    Matharu B; El-Agnaf O; Razvi A; Austen BM
    Peptides; 2010 Oct; 31(10):1866-72. PubMed ID: 20633587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A monoclonal antibody targeting amyloid β (Aβ) restores complement factor I bioactivity: Potential implications in age-related macular degeneration and Alzheimer's disease.
    Lashkari K; Teague G; Chen H; Lin YQ; Kumar S; McLaughlin MM; López FJ
    PLoS One; 2018; 13(5):e0195751. PubMed ID: 29782502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunotherapy for Alzheimer's disease].
    Falkentoft AC; Hasselbalch SG
    Ugeskr Laeger; 2016 Jan; 178(3):V07150588. PubMed ID: 26815584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of drugs for Alzheimer's disease.
    Sun X; Jin L; Ling P
    Drug Discov Ther; 2012 Dec; 6(6):285-90. PubMed ID: 23337815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic Cerebral Hypoperfusion Accelerates Alzheimer's Disease Pathology with Cerebrovascular Remodeling in a Novel Mouse Model.
    Zhai Y; Yamashita T; Nakano Y; Sun Z; Shang J; Feng T; Morihara R; Fukui Y; Ohta Y; Hishikawa N; Abe K
    J Alzheimers Dis; 2016 Jun; 53(3):893-905. PubMed ID: 27314529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulation of AβPP processing alleviates amyloid-β-related pathology in Alzheimer's disease transgenic mice.
    Arbel-Ornath M; Becker M; Rabinovich-Toidman P; Gartner M; Solomon B
    J Alzheimers Dis; 2010; 22(2):469-82. PubMed ID: 20847413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy for Alzheimer's disease: from anti-β-amyloid to tau-based immunization strategies.
    Panza F; Frisardi V; Solfrizzi V; Imbimbo BP; Logroscino G; Santamato A; Greco A; Seripa D; Pilotto A
    Immunotherapy; 2012 Feb; 4(2):213-38. PubMed ID: 22339463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.